Cofermentation ofAspergillus parasiticus strains (SRRC 163 and SRRC 2043) blocked at different steps in the aflatoxin B1 (AFB,) biosynthetic pathway in a synthetic liquid medium or on seeds (cottonseed, corn kernels, and peanuts) resulted in production of AFBI. Strain SRRC 2043 accumulated O-methylsterigmatocystin (OMST), a late precursor in AFB1 biosynthesis, whereas SRRC 163 accumulated averantin, an early precursor in the pathway. Strain SRRC 2043 secreted large amounts of OMST in culture relative to the amounts of several other pathway intermediates secreted into media (by other AFB1 pathway-blocked strains). AFB, production occurred even when colonies of SRRC 163 and SRRC 2043 strains (producing no detectable AFB1) were grown together on an agar medium while physically separated from each other by a filter membrane (0.22-,um pore size). In addition, when mycelia of strain SRRC 163 were added to culture filtrates (containing no mycelia but containing secreted OMST) of strain SRRC 2043, AFB1 production occurred. The results suggested a chemical (rather than genetic) mechanism of complementation for AFB1 production between AFB1 pathway-blocked strains, since no mycelial contact was required between these strains for AFB1 production. The mechanism for chemical complementation involves secretion of OMST by SRRC 2043 and subsequent absorption and conversion of OMST to AFB, by mycelia of strain SRRC 163.
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Many of the biosynthetic intermediates in the aflatoxin B1 (AFB1) pathway have been identified (4, 7, 16, 17, 22, 23) , and several of the enzymes catalyzing the biosynthetic steps in AFB1 formation have been isolated (2, 6, 9, 10, 12, 13, 24, 25) and purified to homogeneity (5, 8, 14) . The generally accepted pathway from the earliest known biosynthetic intermediate to (20, 24) . Mutant strains of Aspergillus parasiticus have been isolated that are blocked at different stages in the AFB, biosynthetic pathway and that accumulate different AFB1 pathway intermediates, such as NOR, AVN, averufin, hydroxyversicolorone, VER A, or OMST (4, 7, 16, 17, 22, 23) , in culture. These mutant strains, however, can convert in culture exogenously added aflatoxin precursors (beyond the point of the block) to AFB1 (7, 16, 17, 19) . Also, diploids of strains blocked at these different steps in AFB1 biosynthesis will produce aflatoxin (3, 18) , since in diploid form they possess all the genetic information necessary for synthesis of AFB1. In addition, in an earlier study from this laboratory, it was observed that during cofermentation of two blocked strains of A. parasiticus, levels of OMST were greatly reduced in the culture with the simultaneous production of aflatoxins (11) . The mechanism of this complementation (chemical or genetic) was not examined in detail in that study.
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Chemical complementation (cross-feeding) for AFB1 biosynthesis between blocked pathway mutants requires the secretion of biosynthetic pathway intermediates by one strain, their uptake by fungal mycelia of the other strain, and conversion of the intermediates to AFB1 by enzymes catalyzing biosynthetic steps downstream from pathway blocks. Little is known about fungal transport mechanisms involved in secretion and/or uptake of metabolites in the AFB, pathway.
The purpose of the present investigation was to utilize selected AFB1 pathway-blocked strains of A. parasiticus to learn more about the secretion and uptake of AFB1 pathway intermediates produced in high levels in mycelia of these pathway-blocked strains. The present study was also designed to determine whether specific cross-feeding of pathway intermediates occurs between aflatoxigenic and/or nonaflatoxigenic strains during fungal strain interactions on various growth media, resulting in subsequent AFB1 production.
MATERIALS AND METHODS
Cultures and culture conditions. Several AFB1 pathwayblocked strains of A. parasiticus Secretion of AFB1 pathway intermediates and AFB1 into AM medium or into a low-sugar resting medium (LSRM) (1) was quantitated by procedures described earlier for analysis of metabolites (7, 19 (19) to quantify the compounds.
The relative rates of secretion of certain AFB1 pathway metabolites by mycelia were also determined. Mycelia of the AFB1-producing strain (SRRC 143) or the AFB1 pathwayblocked strains (SRRC 163 and SRRC 2043) were harvested from AM shake cultures 3 days after inoculation (AFB, pathway metabolites had been produced by this time) (12) and washed with sterile deionized water by filtration on Miracloth to remove metabolites adhering externally to the mycelia. A portion of the damp mycelia (1.0 g) was added to 20 ml of LSRM in a 50-ml Erlenmeyer flask; quantities of AFB1 pathway metabolites secreted into the medium (while shaking at 29°C) were determined, as described above, by removing 0.25-ml aliquots of filtrates (any residual mycelia in the aliquots were removed by centrifugation at 5,000 x g before the assay) at various periods and by analyzing filtrates for the metabolites.
Cofermentation of AFB1 pathway-blocked strains of A. parasiticus. Production of AFB1 was determined during cofermentation of two AFB1 pathway-blocked strains of A. parasiticus; cofermentations were initiated by the same methods as those used for culturing individual strains in liquid medium (AM) (first section of Materials and Methods), except that in addition to inoculating AM medium, we also inoculated sterilized seeds with A. parasiticus spores. Seeds were prepared before inoculation as follows. Seeds were oven dried (50°C) for 3 days, weighed, and autoclaved for 15 min at 121°C, and the moisture content of the dried seeds was adjusted to 30% (by weight) with sterile deionized water. The A. parasiticus strains used in these experiments were SRRC 163 (blocked at the AVN -* averufanin and VER A -> sterigmatocystin biosynthetic steps) and SRRC 2043 (blocked at the OMST -> AFB1 biosynthetic step). An inoculum (200 Rl of spore suspension) of each strain was added separately or together to either 100 ml of AM or to 5 g of selected seeds (peanuts, corn kernels, or cottonseed) and briefly shaken to distribute spore solutions in the media. Liquid (AM) and seed cultures were incubated for 5 and 7 days (without shaking), respectively, at 29°C. AFB1 and OMST were then extracted and quantified from AM cultures as described above and from seed cultures according to reference 2a.
Tests for complementation for AFB, production without contact between mycelia of AFB, pathway-blocked mutants. Table 1) .
The rates of secretion of certain metabolites by mycelia in LSRM were determined. OMST and AFB1 were rapidly secreted from mycelia of strains SRRC 2043 and SRRC 143, respectively, when 72-h-old mycelia (containing AFB1 pathway metabolites) were placed into LSRM (Fig. 1) . Secretion of AVN by strain SRRC 163 was not detected in this experiment.
Cofermentation of two AFB1 pathway-blocked strains of A. parasiticus (SRRC 163 and 2043) on peanuts, corn kernels, and cottonseed and in a synthetic liquid medium (AM) resulted in production of AFB1 in the cultures (Table 2) When colonies of AFB1 pathway-blocked strains SRRC 163 and SRRC 2043 were grown together on an agar medium but separated by a membrane with a pore size small enough to prevent contact between the two strains, AFB1 production occurred (Table 4) . Over 80% of the AFB1 was isolated from the agar medium supporting growth of strain SRRC 163 on one side of the membrane. Levels of AFB, produced by "To obtain culture filtrates, 1 g of washed (see Materials and Methods) 72-h-old mycelia pregrown in liquid medium (1) were transferred into LSRM and then incubated for 6 h with constant shaking at 150 rpm at 29°C; mycelia were removed by filtration (0.45-p.m-pore-size membrane), and filtrates containing secreted AFB, pathway metabolites were incubated in various combinations with mycelia of selected strains. ' Mycelia were added to LSRM containing no AFB1 pathway metabolites as a control. produced by the wild-type strain (SRRC 143). However, these low levels of AFB1 were consistent with the low levels of AFB1 precursor (OMST) diffusing toward SRRC 163 mycelia from the SRRC 2043 mycelia; only 2% of the total OMST produced by colonies of strain SRRC 2043 (growing alone) diffused across the membrane (Table 4) . Strain SRRC 163, although producing AVN in colonies, secreted no detectable AVN into the agar medium. DISCUSSION The most likely mechanism to explain the observed AFB1 production during cofermentation of AFB1 nonproducing strains SRRC 163 and SRRC 2043 begins with the secretion of OMST by SRRC 2043 mycelia and then the uptake and conversion of the secreted OMST to AFB1 by SRRC 163 mycelia. Strain SRRC 163 (unlike strain SRRC 2043) possesses a functional oxidoreductase (10, 12) capable of catalyzing OMST-to-AFB1 conversion. Strain SRRC 2043, although incapable of performing the conversion of OMST to AFB1, can synthesize and rapidly secrete OMST into the medium (Fig. 1) . The facts that mycelia of strain SRRC 2043 are capable of secreting high amounts of OMST into the culture filtrate (present study) and that exogenously added OMST is absorbed efficiently by mycelia of the mutant strain SRRC 163 and converted to AFB1 (7) indicate that when the two AFB1 pathway-blocked strains (SRRC 163 and SRRC 2043) are placed together in cofermentation (this study), the above process probably leads to the complementation for AFB1 production observed. The same process can be mimicked by supplying SRRC 163 mycelia with mycelium-free filtrates of strain SRRC 2043 (containing secreted OMST) (Table 3 ). These observations explain the observed crossfeeding between physically separated colonies of the two strains resulting in AFB1 production (Table 4) , in which complementation for AFB1 production occurred even without physical contact between the two strains (Tables 3 and  4) . A chemical mechanism of complementation is, therefore, indicated in all the cases presented here. However, the present study does not preclude the possibility that complementation under certain conditions could occur by hyphal fusion, anastomosis, and/or by a genetic mechanism (3, 18) requiring physical contact between strains.
Results in the present study demonstrated quantitatively that the mycelial mats in static cultures have a less than 7% capability for secretion of early AFB1 pathway intermediates (NOR, AVN, and VER A) ( Table 1) , whereas greater than 50% of metabolites at or nearer the end of the AFB1 pathway (OMST and AFB1) are secreted by the fungal mycelia (Table  1 and Fig. 1 ). Earlier results from this laboratory (16, 17) suggested, qualitatively, that NOR and VER A pigments were contained in the nonsporulating mycelial balls obtained in shake cultures.
An appreciable number of dead cells may be present in mycelial balls larger than about 400 ,um in diameter as has been suggested for other filamentous fungi (21) . Mycelial mats produced in static cultures in the present study may also contain dead cells. Therefore, a possibility exists that metabolites (NOR, AVN, VER A, OMST, and AFB1) might be released from dead cells, but even if dead fungal tissue was present, the strains still released relatively low amounts of early pathway metabolites (NOR, AVN, and VER A) and high amounts of late pathway metabolites (OMST and AFB1) ( Table 1 ). These results suggest that early aflatoxin pathway precursors are retained in sequestered domains within the cells, a phenomenon that has been observed in secondary metabolism of other filamentous fungi, particularly in the biosynthesis of antibiotics such as penicillin (15) . In this way, the fungus could perform various intracellular enzymatic conversions involved in aflatoxin biosynthesis without premature release of the early pathway intermediates into the medium outside the fungal cell.
Differential release of AFB1 pathway intermediates also could point to a differential mechanism in transport. It could be proposed that an active transport rather than a simple passive and nonspecific diffusion of these compounds from fungal cells may be involved in the secretion of OMST and AFB1 from the mycelia, based on the chemical structures of these metabolites. This hypothesis is currently being investigated in our laboratory.
The biological importance of the chemical complementation mechanism observed in our laboratory as it applies to natural field contamination of seeds with AFB1 is unknown. However, the laboratory results reported here point to certain conditions or restrictions that might limit the degree of field contamination obtained by the chemical complementation mechanism. First of all, under laboratory conditions, AFB1 production by the complementation mechanism was relatively low compared with AFB1 production by the native AFB1-producing strain (SRRC 143), which possesses all the intracellular biosynthetic enzymes necessary for efficient AFB1 production. However, the relatively low AFB1 synthesis occurring during cofermentation by AFB1 pathway-APPL. ENVIRON. MICROBIOL.
on July 5, 2017 by guest http://aem.asm.org/ Downloaded from blocked strains (compared with the native strain) may be due to inefficient cross-feeding of AFB1 pathway metabolites occurring during the process of secretion and/or uptake of the metabolites by mycelia. Second, inconsistent results were obtained (data not shown) unless the moisture content of seed media was maintained at a minimum of 30%, suggesting that high moisture could be a critical requirement for consistent cross-feeding to occur in the laboratory or in the field. Third, results in the present study indicate that the addition of fungal filtrates containing the AFB1 precursors (e.g., OMST) to a native AFB1 producer did not increase the degree of AFB1 production by the strain (Table 3) ; perhaps certain AFB1 pathway enzymes of the native AFB1 producer are already operating at their maximum rate and the addition of more enzyme substrate does not increase an already high AFB1 production.
In conclusion, the present study demonstrated that under certain conditions, cross-feeding of metabolites of the AFBI pathway is possible between nonaflatoxigenic fungal strains, leading to AFB1 synthesis. This complementation, however, appears to depend on the nature of the block in the complementing strains, since only late intermediates in the AFB1 biosynthetic pathway are released into the surrounding medium.
It is known that native AFB1 nonproducing strains of A. parasiticus that produce certain AFB1 precursors exist in the field; the OMST-producing strain SRRC 2043 is a field isolate ofA. parasiticus (7) . Therefore, the possibility exists that the presence of high populations of such fungal strains in the field could contribute to the total AFB1 contamination of field crops; the extent of this contribution, however, remains uncertain. This possibility has implications for the effectiveness of use of aflatoxin pathway-blocked strains released for biocontrol of aflatoxin contamination. It is conceivable that in a limited number of cases each blocked strain could complement other blocked strains. However, any contribution of the mutant strain in increasing toxin production by a wild-type strain would be extremely difficult to assess because of the apparently low aflatoxin production resulting from the cross-feeding relative to the high aflatoxin production by the wild-type strain.
